LIGHT, a New Member of the TNF Superfamily, and Lymphotoxin α Are Ligands for Herpesvirus Entry Mediator
1998 · Immunity · 770 citations
https://doi.org/10.1016/s1074-7613(00)80455-0
D
Davide Mauri
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
245
Papers
9.7K
Citations
42
h-index
81
i10-index
Davide Mauri is an academic researcher. The author has contributed to research in topics: Breast Cancer Treatment Studies & Global Cancer Incidence and Screening & Cancer Immunotherapy and Biomarkers. The author has an h-index of 42, co-authored 209 publications.
ORCID: 0000-0002-8501-5986Papers by this author
worksTrastuzumab combined to neoadjuvant chemotherapy in patients with HER2-positive breast cancer: A systematic review and meta-analysis
2011 · The Breast · 116 citations
https://doi.org/10.1016/j.breast.2011.06.009
Hyperthermic intraperitoneal chemotherapy (HIPEC) for the management of primary advanced and recurrent ovarian cancer: a systematic review and meta-analysis of randomized trials
2022 · ESMO Open · 105 citations
https://doi.org/10.1016/j.esmoop.2022.100586
Cross-reactivity of T cell lines and clones to β-lactam antibiotics
1996 · The Journal of Immunology · 98 citations
https://doi.org/10.4049/jimmunol.157.3.1071
Lymphotoxin αβ Is Expressed on Recently Activated Naive and Th1-Like CD4 Cells but Is Down-Regulated by IL-4 During Th2 Differentiation
1999 · The Journal of Immunology · 58 citations
https://doi.org/10.4049/jimmunol.162.3.1333
The prognostic and predictive impact of low estrogen receptor expression in early breast cancer: a systematic review and meta-analysis
2021 · ESMO Open · 53 citations
https://doi.org/10.1016/j.esmoop.2021.100289
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat